Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.
Dierks J, Gaspersz MP, Belkouz A, van Vugt JLA, Coelen RJS, de Groot JWB, Ten Tije AJ, Meijer WG, Pruijt JFM, van Voorthuizen T, van Spronsen DJ, Rentinck M, Ten Oever D, Smit JM, Otten HM, van Gulik TM, Wilmink JW, Groot Koerkamp B, Klümpen H. Dierks J, et al. Among authors: belkouz a. Acta Oncol. 2018 Jun;57(6):807-812. doi: 10.1080/0284186X.2017.1418532. Epub 2017 Dec 21. Acta Oncol. 2018. PMID: 29265948
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M, Belkouz A, van der Geest LG, van Gulik TM, van Hooft JE, de Meijer VE, Haj Mohammad N, de Reuver PR, Verheij J, de Vos-Geelen J, Wilmink JW, Groot Koerkamp B, Klümpen HJ, Besselink MG; Dutch Pancreatic Cancer Group. Strijker M, et al. Among authors: belkouz a. Acta Oncol. 2019 Jul;58(7):1048-1055. doi: 10.1080/0284186X.2019.1590634. Epub 2019 Mar 25. Acta Oncol. 2019. PMID: 30907207
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A, Wilmink JW, Haj Mohammad N, Hagendoorn J, de Vos-Geelen J, Dejong CHC, Homs MYV, Groot Koerkamp B, van Gulik TM, van Oijen MGH, Punt CJA, Klümpen H. Belkouz A, et al. Crit Rev Oncol Hematol. 2020 Jul;151:102975. doi: 10.1016/j.critrevonc.2020.102975. Epub 2020 Apr 27. Crit Rev Oncol Hematol. 2020. PMID: 32464483 Free article. Review.
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma: A Retrospective Cohort Study.
Nooijen LE, Franken LC, Belkouz A, Oulad Abdennabi I, Besselink MG, Busch OR, Swijnenburg RJ, Klümpen HJ, Erdmann JI. Nooijen LE, et al. Among authors: belkouz a. Am J Clin Oncol. 2021 Oct 1;44(10):526-532. doi: 10.1097/COC.0000000000000861. Am J Clin Oncol. 2021. PMID: 34469345
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma.
Belkouz A, Van Roessel S, Strijker M, van Dam JL, Daamen L, van der Geest LG, Balduzzi A, Cacciaguerra AB, van Dieren S, Molenaar Q, Groot Koerkamp B, Verheij J, Van Eycken E, Malleo G, Hilal MA, van Oijen MGH, Borbath I, Verslype C, Punt CJA, Besselink MG, Klümpen HJ; Dutch Pancreatic Cancer Group (DPCG). Belkouz A, et al. Br J Cancer. 2022 May;126(9):1280-1288. doi: 10.1038/s41416-021-01687-1. Epub 2022 Jan 17. Br J Cancer. 2022. PMID: 35039626 Free PMC article.
12 results